Ignite Creation Date:
2024-05-05 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00518206
Status:
COMPLETED
Last Update Posted:
2022-10-25
First Post:
2007-08-16
Brief Title:
Study of NY-ESO-1 ISCOMATRIX in Patients With Measurable Stage III or IV Melanoma
Sponsor:
Ludwig Institute for Cancer Research
Organization:
Ludwig Institute for Cancer Research
Organization Data
Organization:
Ludwig Institute for Cancer Research
Class:
OTHER
Study ID:
LUD2002-013
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ludwig Institute for Cancer Research
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Peter MacCallum Cancer Institute | UNKNOWN |
| Austin Health | OTHER_GOV |